C
Charles DeCarli
Researcher at University of California, Davis
Publications - 721
Citations - 77364
Charles DeCarli is an academic researcher from University of California, Davis. The author has contributed to research in topics: Dementia & Hyperintensity. The author has an hindex of 125, co-authored 614 publications receiving 65820 citations. Previous affiliations of Charles DeCarli include University of Southern California & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Kidney Function Is Not Related to Brain Amyloid Burden on PET Imaging in The 90+ Study Cohort.
Wei Ling Lau,Mark Fisher,Evan Fletcher,Charles DeCarli,Hayden R. Troutt,Maria M. Corrada,Claudia H. Kawas,Annlia Paganini-Hill +7 more
TL;DR: In this article, the authors evaluated serum cystatin C-estimated glomerular filtration rate (eGFR), brain amyloid-β positron emission tomography (PET) imaging, and cognitive function in 166 participants from The 90+ Study.
Journal ArticleDOI
Exercise-related middle cerebral artery territory stroke.
TL;DR: Two cases of internal carotid dissection resulting in stroke in the middle cerebral artery territory are seen, shortly after two different, commonly used, simple exercise programs.
Journal ArticleDOI
Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories.
Sarah F Ackley,Eleanor Hayes-Larson,Willa D. Brenowitz,Kaitlin N. Swinnerton,Dan M Mungas,Evan Fletcher,Baljeet Singh,Rachel A. Whitmer,Charles DeCarli,M. Maria Glymour +9 more
TL;DR: In this paper, the authors evaluated the extent to which amyloid-PET improves prediction of future cognitive changes over and above predictions based only on sociodemographics and past cognitive measures.
Journal Article
Comparing Semi-quantitative and Volumetric Measurements of MRI White Matter Hyperintensities: The Northern Manhattan Study (S62.007)
Carly Oboudiyat,Hannah Gardener,Chensy Marquez,Mitchell S.V. Elkind,Ralph L. Sacco,Charles DeCarli,Clinton B. Wright +6 more
TL;DR: The authors' volumetric and visual rating measures of WMH were strongly correlated, but the volumetrical measure was associated with more risk factors in this community-based sample, and user-friendly WMH scales that capture vascular risk are needed.
Journal ArticleDOI
Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate
Aniket Mishra,Cécile Duplàa,Dina Vojinovic,Hideaki Suzuki,Muralidharan Sargurupremraj,Nuno R. Zilhão,Shuo Li,Traci M. Bartz,Xueqiu Jian,Wei Zhao,Edith Hofer,Katharina Wittfeld,Sarah E. Harris,Sandra van der Auwera-Palitschka,Michelle Luciano,Joshua C. Bis,Hieab H.H. Adams,Claudia L. Satizabal,Rebecca F. Gottesman,Piyush Gampawar,Robin Bülow,Stefan Weiss,Miao Yu,Mark E. Bastin,Oscar L. Lopez,Meike W. Vernooij,Alexa S. Beiser,Uwe Völker,Tim Kacprowski,Aicha Soumare,Jennifer A. Smith,David S. Knopman,Zoe Morris,Yicheng Zhu,Jerome I. Rotter,Carole Dufouil,Maria del C. Valdés Hernández,Susana Muñoz Maniega,Mark Lathrop,Eric Boerwinkle,Reinhold Schmidt,Masafumi Ihara,Bernard Mazoyer,Qiong Yang,Anne Joutel,Elisabeth Tournier-Lasserve,Lenore J. Launer,Ian J. Deary,Thomas H. Mosley,Philippe Amouyel,Charles DeCarli,Bruce M. Psaty,Christophe Tzourio,Sharon L.R. Kardia,Hans J. Grabe,Alexander Teumer,Cornelia M. van Duijn,E. E. Schmidt,Joanna M. Wardlaw,M. Arfan Ikram,Myriam Fornage,Vilmundur Gudnason,Sudha Seshadri,Paul M. Matthews,W. T. Longstreth,Thierry Couffinhal,Stéphanie Debette +66 more
TL;DR: Overall, a comprehensive gene-mapping study and preliminary functional evaluation suggests a putative role of TRIM47 in the pathophysiology of cerebral small vessel disease, making it an important candidate for extensive in vivo explorations and future translational work.